Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis


Cite item

Full Text

Abstract

Antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) are rare autoimmune disorders and characterized by severe multiple organ lesions with a potential fatal outcome. AAV comprises granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA). Early diagnosis and treatment can significantly improve the AAV prognosis, but there are can be difficult, largely due to the lack of criteria for the classification MPA, whose main difference is the absence of granulomatous inflammation. The presented paper deals with the results of the analysis of 251 patients with AAV (mean age 43.1 ± 15.9 years, men 40%, disease duration 3 (0,2-28,5) years, ANCA 100%), based on which the diagnostic algorithm was developed. The algorithm steps include classification criteria of EGPA as well as surrogate markers for granulomatous inflammation (SG) and vasculitis (SV). MPA confirmed by the absence of criteria for EGPA, the presence of SV and the absence of SG. Due to the algorithm usage, nosological affiliation of AAV was determined in 99% patients. Both GPA and MPA were the most common (53% and 37%), while EGPA was rare (9%). In MPA group the overall mortality was higher (18%) than GPA and EGPA (7-5%), p=0.003. In MPA with anti-proteinase 3 antibody the two-year survival rate was lower than those with anti-myeloperoxidase antibody (p=0.04), mainly because of the high risk for alveolar hemorrhage and rapidly progressive glomerulonephritis. Relapses occurred more frequently in EGPA (80%) and in GPA (64%) and less frequently in MPA (49%). The group differences confirm diagnostic value of the algorithm. In conclusion, the proposed algorithm will help to improve the diagnosis of AAV. It is important that crucial in the AAV diagnosis belongs focused and systematic clinical examination of patients.

About the authors

T V Beketova

V.A. Nasonova Scientific Research Institute of Rheumatology

Email: tvbek@rambler.ru
в.н.с., ORCID: 0000-0003-2641-9785; тел.: 8(916)320-58-55 Moscow, Russia

References

  1. Jennette J.C, Falk R.J, Bacon P.A, Basu N, Cid M.C, Ferrario F, Flores-Suarez L.F, Gross W.L, Guillevin L, Hagen E.C, Hoffman G.S, Jayne D.R, Kallenberg C.G, Lamprecht P, Langford C.A, Luqmani R.A, Mahr A.D, Matteson E.L, Merkel P.A, Ozen S, Pusey C.D, Rasmussen N, Rees A.J, Scott D.G, Specks U, Stone J.H, Takahashi K, Watts R.A. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. https://doi.org/ 10.1002/art.37715
  2. Leavitt R.Y, Fauci A.S, Bloch D.A, Michel B.A, Hunder G.G, Arend W.P, Calabrese L.H, Fries J.F, Lie J.T, Lightfoot R.W Jr, et al. The American college of rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthr Rheum. 1990;33:1101-7.
  3. Masi A.T, Hunder G.G, Lie J.T, Michel B.A, Bloch D.A, Arend W.P, Calabrese L.H, Edworthy S.M, Fauci A.S, Leavitt R.Y, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094-100.
  4. Jayne D. Challenges in the management of microscopic polyangiitis. Current opinion in rheumatology. 2008;20(1):3-9. https://doi.org/ 10.1097/BOR.0b013e3282f370d1
  5. Bossuyt X, Cohen Tervaert J.W, Arimura Y, Blockmans D, Flores-Suárez L.F, Guillevin L, Hellmich B, Jayne D, Jennette J.C, Kallenberg C.G.M, Moiseev S, Novikov P, Radice A, Savige J.A, Sinico R.A, Specks U, van Paassen P, Zhao M.H, Rasmussen N, Damoiseaux J, Csernok E. Position paper: Revised 2017 international consensus ont esting of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol. 2017;13(11):683-692. http://dx.doi.org/ 10.1038/nrrheum.2017.140
  6. Devaney K.O, Travis W.D, Hoffman G, Leavitt R, Lebovics R, Fauci A.S. Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol. 1990;14(6):555-64.
  7. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert J.W, Scott D. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222-7.
  8. Yates M, Watts R.A, Bajema I.M, Cid M.C, Crestani B, Hauser T, Hellmich B, Holle J.U, Laudien M, Little M.A, Luqmani R.A, Mahr A, Merkel P.A, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalçındağ N, Jayne D.R, Mukhtyar C. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75(9):1583-94. https://doi.org/10.1136/annrheumdis-2016-209133
  9. Luqmani R.A, Bacon P.A, Moots R.J, Janssen B.A, Pall A, Emery P, Savage C, Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87(11):671-678.
  10. Бекетова Т.В. Асимптомное течение поражения легких при гранулематозе с полиангиитом (Вегенера). Научно - практическая ревматология. 2012;1:102-104. http://dx.doi.org/10.14412/1995-4484-2014-102-104
  11. Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis and rheumatism. 2000;43(11):2481-2487.
  12. Catanoso M, Macchioni P, Boiardi L, Manenti L, Tumiati B, Cavazza A, Luberto F, Pipitone N, Salvarani C. Epidemiology of granulomatosis with polyangiitis (Wegener's granulomatosis) in Northern Italy: a 15-year population - based study. Seminars in arthritis and rheumatism. 2014;44(2):202-207. http://dx.doi.org/10.1016/j.semarthrit.2014.05. 005
  13. Watts R.A, Lane S.E, Bentham G, Scott D.G. Epidemiology of systemic vasculitis. A ten year study in the United Kingdom. Arthritis and rheumatism. 2000;43(2):414-419.
  14. Nesher G, Ben-Chetrit E, Mazal B, Breuer G. The Incidence of Primary Systemic Vasculitis in Jerusalem: A 20-year Hospital - based Retrospective Study. J Rheumatol. 2016;43(6):1072-7. http://dx.doi.org/ 10.3899/jrheum.150557
  15. Andrews M, Edmunds M, Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s- Is theere are increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J Royal Coll Phys Lond. 1990; 24:284-8.
  16. Savage C.O, Winearls C.G, Evans D.J, Rees A.J, Lockwood C.M. Microscopic polyarteritis: presentation, pathology and prognosis. QJM. 1985;56(220):467-483.
  17. Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B. Microscopic polyangiitis: clinical and laboratory findings in eighty - five patients. Arthritis rheum. 1999;42(3):421-430.
  18. Lane S.E, Watts R.A, Shepstone L, Scott D.G. Primary systemic vasculitis: clinical features and mortality. QJM. 2005;98(2):97-111.
  19. Ahn J.K, Hwang J.W, Lee J, Jeon C.H, Cha H.S, Koh E.M. Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea. Rheumatol Int. 2011;32(10):2979-2986.
  20. Huang C.K, Fang H.C, Chou K.J, Wang J.S, Lee P.T, Chang T.Y, Hsu C.Y, Huang W.C, Chung H.M, Chen C.L. Clinical features of microscopic polyangiitis: a cohort study in a southern Taiwan medical center. Acta Nephrologica. 2012;26(4):198-205. http://dx.doi.org/10.6221/AN. 2011028
  21. Захарова Е.В., Яковлев В.Н., Виноградова О.В., Шейх Ж.В., Жидкова Н.В., Алексеев В.Г. ANCA-ассоциированные васкулиты с поражением легких и почек: клинико - морфологическая характеристика, лечение, исходы. Клиническая медицина. 2013;91(7):38-43.
  22. Pagnoux C, Carette S, Khalidi N.A, Walsh M, Hiemstra T.F, Cuthbertson D, Langford C, Hoffman G, Koening C.L, Monach P.A, Moreland L, Mouthon L, Seo P, Specks U, Ytterberg S, Westman K, Hoglund P, Harper L, Flossman O, Luqmani R, Savage C.O, Rasmussen N, de Groot K, Tesar V, Jayne D, Merkel P.A, Guillevin L. Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts. Clin Exp Rheumatol. 2015;33(2 Suppl 89):77-83.
  23. Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011;90(1):19-27. http://dx.doi.org/10.1097/MD.0b013e318205a4c6
  24. Comarmond C, Pagnoux C, Khellaf M, Cordier J.F, Hamidou M, Viallard J.F, Maurier F, Jouneau S, Bienvenu B, Puéchal X, Aumaître O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogué B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long - term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis rheum. 2013;65(1):270-281. http://dx.doi.org/10.1002/art.37721
  25. Mohammad A.J, Jacobsson L.T, Westman K.W, Sturfelt G, Segelmark M. Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford). 2009;48(12):1560-1565. http://dx.doi.org/ 10.1093/rheumatology/kep304
  26. Miloslavsky E.M, Lu N, Unizony S, Choi H.K, Merkel P.A, Seo P, Spiera R, Langford C.A, Hoffman G.S, Kallenberg C.G, St Clair E.W, Tchao N.K, Fervenza F, Monach P.A, Specks U, Stone J.H. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. Arthritis Rheumatol. 2016;68(12):2945-2952. http://dx.doi.org/10.1002/art.39812
  27. Schönermarck U, Lamprecht P, Csernok E, Gross W.L. Prevalence and spectrum of rheumatic diseases associated with proteinase 3 antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford). 2001;40(2):178-184.
  28. Zycinska K, Wardyn K.A, Zycinski Z, Zielonka T.M. Association between clinical activity and high - resolution tomography findings in pulmonary. Physiol Pharmacol. 2008;59(Suppl. 6):833-838.
  29. Pagnoux C, Guillevin L. Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol. 2010;22(1):21-28. http://dx.doi. org/10.1097/BOR.0b013e328333390b
  30. Stangou M, Asimaki A, Bamichas G, Christidou F, Zoumbaridis N, Natse T, Galanis N, Christaki P, Patakas D, Sombolos K. Factors influencing patient survival and renal function outcome in pulmonary - renal syndrome associated with ANCA (+) vasculitis: A single - center experience. J Nephrol. 2005;18(1):35-44.
  31. Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht H.D. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant. 2004;19(6):1403-1411.
  32. Homma S, Matsushita H, Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody - associated vasculitides. Respirology. 2004;9(2):190-196.
  33. Ando M, Miyazaki E, Ishii T, Mukai Y, Yamasue M, Fujisaki H, Ito T, Nureki S, Kumamoto T. Incidence of myeloperoxidase anti - neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis. Respir Med. 2013;107(4):608-615. http://dx.doi.org/10.1016/j.rmed.2013.01.006
  34. Foulon G, Delaval P, Valeyre D, Wallaert B, Debray M.P, Brauner M, Nicaise P, Cadranel J, Cottin V, Tazi A, Aubier M, Crestani B. ANCA-associated lung fibrosis: Analysis of 17 patients. Respir Med. 2008;102(10):1392-1398. http://dx.doi.org/10.1016/j.rmed.2008.04. 023
  35. Puéchal X, Pagnoux C, Perrodeau É, Hamidou M, Boffa J.J, Kyndt X, Lifermann F, Papo T, Merrien D, Smail A, Delaval P, Hanrotel-Saliou C, Imbert B, Khouatra C, Lambert M, Leské C, Ly K.H, Pertuiset E, Roblot P, Ruivard M, Subra J.F, Viallard J.F, Terrier B, Cohen P, Mouthon L, Le Jeunne C, Ravaud P, Guillevin L. Long - term outcomes of the WEGENT trial on remission - maintenance for granulomatosis with polyangiitis or microscopic polyangiitis. Arthritis Rheumatol. 2016;68(3):690-701.
  36. Walsh M, Flossmann O, Berden A, Westman K, Höglund P, Stegeman C, Jayne D. Risk factors for relapse of antineutrophil cytoplasmic antibody - associated vasculitis. Arthritis Rheumatol. 2012;64(2):542-548. http://dx.doi.org/10.1002/art.33361
  37. Sada K.E, Yamamura M, Harigai M, Fujii T, Takasaki Y, Amano K, Fujimoto S, Muso E, Murakawa Y, Arimura Y, Makino H. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study. Arthritis Res Ther. 2015;17(1):305. http://dx.doi.org/10. 1186/s13075-015-0815-y
  38. Li Z.Y, Chang D.Y, Zhao M.H, Chen M. Predictors of treatment resistance and relapse in ANCA-associated vasculitis: a study of 439 cases in a single Chinese center. Arthritis Rheumatol. 2014;66(7):1920-1926. http://dx.doi.org/10.1002/art.38621
  39. Pierrot-Deseilligny Despujol C, Pouchot J, Pagnoux C, Coste J, Guillevin L. Predictors at diagnosis of a first Wegener's granulomatosis relapse after obtaining complete remission. Rheumatology(Oxford). 2010;49(11):2181-2190. http://dx.doi.org/10.1093/rheumatology/ keq244
  40. Moiseev S, Novikov P, Jayne D, Mukhin N. End - stage renal disease in ANCA-associated vasculitis. Nephrol Dial Transplant. 2017;32(2): 248-253. http://dx.doi.org/10.1093/ndt/gfw046
  41. Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J, Humbert M, Jayne D, Jennette J.C, Lazor R, Mahr A, Merkel P.A, Mouthon L, Sinico R.A, Specks U, Vaglio A, Wechsler M.E, Cordier J.F, Guillevin L. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Int Med. 2015;26(7):545-553. http://dx.doi.org/10.1016/j.ejim.2015.04.022

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies